XML 81 R4.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenues:        
Total revenues $ 70,061 $ 2,069 $ 148,069 $ 53,875
Costs and expenses:        
Cost of goods sold 5,213 137 12,886 137
Research and development 160,796 139,945 453,813 374,384
Selling, general and administrative 120,351 116,545 322,728 273,671
Total costs and expenses 286,360 256,627 789,427 648,192
Loss from operations (216,299) (254,558) (641,358) (594,317)
Other income (expense):        
Interest income 9,889 6,796 26,195 18,691
Other (expense) income (2,519) 2,925 (2,929) 5,468
Change in fair value of liability obligation 0 0 9,422 0
Gain on litigation settlement 0 0 0 20,564
Total other income 7,370 9,721 32,688 44,723
Loss before income taxes (208,929) (244,837) (608,670) (549,594)
Benefit (provision) for income taxes 394 (445) (1,261) (462)
Net loss $ (208,535) $ (245,282) $ (609,931) $ (550,056)
Net loss per common share - basic and diluted (in dollars per share) $ (1.92) $ (2.43) $ (5.63) $ (5.48)
Weighted-average common shares used to compute basic and diluted net loss per common share (in shares) 108,701 100,783 108,427 100,430
Comprehensive loss:        
Net loss $ (208,535) $ (245,282) $ (609,931) $ (550,056)
Unrealized (loss) gain on marketable securities, net of tax (50) 415 772 1,041
Foreign currency translation 1,439 0 2,281 0
Defined benefit pension plans 71 0 (4,211) 0
Comprehensive loss (207,075) (244,867) (611,089) (549,015)
Net Revenues from Collaborators        
Revenues:        
Total revenues 23,995 1,609 37,481 53,415
Product Revenues, Net        
Revenues:        
Total revenues $ 46,066 $ 460 $ 110,588 $ 460